73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New therapeutic avenue in the fight against chronic liver disease

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research
Do pancreatic cysts become cancerous?

Do pancreatic cysts become cancerous?

by Christos Fountzilas, Md,Roswell Park Cancer InstituteCredit: Roswell Park Cancer InstituteWhat is a pancreatic cyst?Pancreatic cysts are water or mucus filled structures in the pancreas, simi

Do pancreatic cysts become cancerous?

by Christos Fountzilas, Md,Roswell Park Cancer InstituteCredit: Roswell Park Cancer InstituteWhat is a pancreatic cyst?Pancreatic cysts are water or mucus filled structures in the pancreas, simi
Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu
A new combination therapy regimen shows promising results for prostate cancer

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress
Tackling resistance to HIF2 drugs with an RNA-based therapy

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca
Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n
New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in
Team pioneers cancer treatment that targets bone metastases while sparing bone

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells
Researchers pinpoint tumor-related protein, slow progression of cancers

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.
New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body

New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children

byElsevierLeft: Gross images of livers from mice transfected with β-catenin and YAP1(β-Y), β-catenin and YAP1 plus dominant negative HSF1 (dnHSF1-β-Y) and normal (control). Right: Liver to body
Research illuminates a therapeutic strategy to induce cancer cell death

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a
Brain cancer breakthroughs using the immune system offer hope against glioblastoma

Brain cancer breakthroughs using the immune system offer hope against glioblastoma

by Lisa Jarvis, Bloomberg OpinionCredit: Human Brain ProjectA flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain canc

Brain cancer breakthroughs using the immune system offer hope against glioblastoma

by Lisa Jarvis, Bloomberg OpinionCredit: Human Brain ProjectA flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain canc